Universi19
This role involves conducting research on the molecular basis of cardiovascular diseases, focusing on signal pathways and pathomechanisms contributing to heart failure and arrhythmias. The position includes performing molecular biology, protein biochemistry, cell biology, and histological methods, as well as participating in medical teaching. It offers structured doctoral supervision and opportunities for international conference presentations.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Universi19.
Universi19 didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role